| 2018 | Elevated expression of pancreatic adenocarcinoma upregulated factor (PAUF) is associated with poor prognosis and chemoresistance in epithelial ovarian cancer.
| SCIENTIFIC REPORTS |
| 2009 | Endometrial osteopontin mRNA expression and plasma osteopontin levels are increased in patients with endometriosis | AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY |
| 2008 | Endometrial stromal sarcomas: a retrospective analysis of 28 patients, single center experience for 20 years
| CANCER RESEARCH AND TREATMENT |
| 2010 | Epidemiological characteristics of ovarian cancer in Korea
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2010 | ER-60 (PDIA3) is highly expressed in a newly established serous ovarian cancer cell line, YDOV-139 | INTERNATIONAL JOURNAL OF ONCOLOGY |
| 2018 | Establishment of five immortalized human ovarian surface epithelial cell lines via SV40 T antigen or HPV E6/E7 expression
| PLOS ONE |
| 2007 | Evaluation of serum and urinary angiogenic factors in patients with endometriosis | AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY |
| 2016 | Expression of fibroblast growth factor receptor family members is associated with prognosis in early stage cervical cancer patients
| JOURNAL OF TRANSLATIONAL MEDICINE |
| 2007 | Expression of human leukocyte antigen-G and its correlation with interleukin-10 expression in cervical carcinoma | INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS |
| 2009 | Expression of interleukin-5 and tumor necrosis factor alpha in cervical carcinoma
| Clinical and Vaccine Immunology |
| 2014 | Expression of Stress-Induced Phosphoprotein1 (STIP1) is Associated with Tumor Progression and Poor Prognosis in Epithelial Ovarian Cancer | GENES CHROMOSOMES & CANCER |
| 2008 | Expression of the p16 and Ki-67 in relation to the grade of cervical intraepithelial neoplasia and high-risk human papillomavirus infection.
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2006 | Expression profiling of cyclin B1 and D1 in cervical carcinoma | EXPERIMENTAL ONCOLOGY |
| 2011 | Feasibility and surgical outcomes of laparoscopic metastasectomy in the treatment of ovarian metastases from gastric cancer. | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2009 | Functional polymorphism in manganese superoxide dismutase and antioxidant status: their interactions on the risk of cervical intraepithelial neoplasia and cervical cancer. | GYNECOLOGIC ONCOLOGY |
| 2022 | Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
| CLINICAL CANCER RESEARCH |
| 2008 | Genomic and proteomic characterization of YDOV-157, a newly established human epithelial ovarian cancer cell line. | MOLECULAR AND CELLULAR BIOCHEMISTRY |
| 2005 | Germline Mutations of BRCA1 and BRCA2 in Korean sporadic ovarian carcinoma | GYNECOLOGIC ONCOLOGY |
| 2017 | HDAC1 Upregulation by NANOG Promotes Multidrug Resistance and a Stem-like Phenotype in Immune Edited Tumor Cells | CANCER RESEARCH |
| 2023 | High ATP6V1B1 expression is associated with poor prognosis and platinum‑based chemotherapy resistance in epithelial ovarian cancer
| ONCOLOGY REPORTS |
| 2022 | HIGH EXPRESSION OF PHOSPHODIESTERASE 1 (PDE1A) PROMOTES POOR PROGNOSIS AND ASSOCIATED WITH PLATINUM BASED CHEMOTHERAPY RESISTANCE IN EPITHELIAL OVARIAN CANCER | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2022 | HIGH EXPRESSION OF TRAFFICKING PROTEIN TRANSMEMBRANE P24 TRAFFICKING PROTEIN9 PROMOTES POOR PROGNOSIS OF EPITHELIAL OVARIAN CANCER | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2022 | HIGH EXPRESSION OF VACUOLAR-ATPASE SUBUNIT ATP6V1B1 PROMOTES POOR PROGNOSIS AND TUMORIGENIC CHARACTERISTICS IN EPITHELIAL OVARIAN CANCER | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2022 | High FKBPL expression contributes to cell proliferation by regulating the cell cycle and affects prognosis in ovarian cancer patients | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2000 | High glucose-induced intercellular adhesion molecule-1 (ICAM-1) expression through an osmotic effect in rat mesangial cells is PKC-NF-kappa B-dependent. | Diabetologia |
| 2023 | High-Dose Selenium Induces Ferroptotic Cell Death in Ovarian Cancer
| INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
| 2020 | HSP90A inhibition promotes anti-tumor immunity by reversing multi-modal resistance and stem-like property of immune-refractory tumors
| NATURE COMMUNICATIONS |
| 2012 | Human chorionic gonadotrophin regression rate as a predictive factor of postmolar gestational trophoblastic neoplasm in high-risk hydatidiform mole: a case-control study | EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY |
| 2018 | Human Papillomavirus 16 Oncoproteins Downregulate the Expression of miR-148a-3p, miR-190a-5p, and miR-199b-5p in Cervical Cancer
| BIOMED RESEARCH INTERNATIONAL |
| 2023 | Hyperthermic Intraperitoneal Chemotherapy After Interval Cytoreductive Surgery for Patients With Advanced-Stage Ovarian Cancer Who Had Received Neoadjuvant Chemotherapy | JAMA SURGERY |
| 2022 | Identification of a novel gene signature in second-trimester amniotic fluid for the prediction of preterm birth
| SCIENTIFIC REPORTS |
| 2003 | Identification of Epithelial Cell Adhesion Molecule Autoantibody in Patients with Ovarian Cancer
| CLINICAL CANCER RESEARCH |
| 2022 | Identification of Prognostic Markers of Gynecologic Cancers Utilizing Patient-Derived Xenograft Mouse Models
| CANCERS |
| 2014 | Incorporation of pazopanib in maintenance therapy of ovarian cancer | JOURNAL OF CLINICAL ONCOLOGY |
| 2022 | LATE-BREAKING ABSTRACT PRESENTATION: COMPARATIVE EFFECTIVENESS OF HIPEC FOLLOWING INTERVAL CYTOREDUCTIVE SURGERY IN PATIENTS WITH ADVANCED-STAGE OVARIAN CANCER UNDERGOING NEOADJUVANT CHEMOTHERAPY: MULTICENTER, PROSPECTIVE, COHORT STUDY (KGOG 3042) | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2021 | LC3B upregulation by NANOG promotes immune resistance and stem-like property through hyperactivation of EGFR signaling in immune-refractory tumor cells
| AUTOPHAGY |
| 2009 | Lipocalin2 expressions correlate significantly with tumor differentiation in epithelial ovarian cancer
| JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY |
| 2013 | Loss of ARID1A/BAF250a expression is linked to tumor progression and adverse prognosis in cervical cancer | HUMAN PATHOLOGY |
| 2019 | Loss of Both USP10 and p14ARF Protein Expression Is an Independent Prognostic Biomarker for Poor Prognosis in Patients With Epithelial Ovarian Cancer | Cancer genomics & Proteomics |
| 2016 | Makorin Ring Finger Protein 1 as Adjunctive Marker in Liquid-based Cervical Cytology
| MEDICINE |
| 2004 | Malignant mixed mullerian tumor of fallopian tube with multiple distinct heterologous components | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2021 | MEK/ERK signaling is a critical regulator of high-risk human papillomavirus oncogene expression revealing therapeutic targets for HPV-induced tumors
| PLOS PATHOGENS |
| 2014 | MICA/B and ULBP1 NKG2D ligands are independent predictors of good prognosis in cervical cancer.
| BMC CANCER |
| 2006 | Microarray comparative genomic hybridization을 이용한 진행된 장액성 난소암의 염색체 변화 분석 | Korean Journal of Gynecologic Oncology (부인종양) |
| 2008 | MicroRNA expression profiles in serous ovarian carcinoma
| CLINICAL CANCER RESEARCH |
| 2012 | MicroRNA profiling of a CD133(+) spheroid-forming subpopulation of the OVCAR3 human ovarian cancer cell line
| BMC MEDICAL GENOMICS |
| 2018 | Mitochondrial reprogramming via ATP5H loss promotes multimodal cancer therapy resistance
| JOURNAL OF CLINICAL INVESTIGATION |
| 2021 | Modulated electro-hyperthermia with weekly paclitaxel or cisplatin in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: The KGOG 3030 trial
| EXPERIMENTAL AND THERAPEUTIC MEDICINE |
| 2009 | Molecular characterization of a new ovarian cancer cell line, YDOV-151, established from mucinous cystadenocarcinoma.
| TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE |
| 2009 | Multiplication of neutrophil and monocyte counts (MNM) as an easily obtainable tumour marker for cervical cancer. | BIOMARKERS IN MEDICINE |
| 2022 | NANOG confers resistance to complement-dependent cytotoxicity in immune-edited tumor cells through up-regulating CD59
| SCIENTIFIC REPORTS |
| 2022 | NANOG regulates epithelial-mesenchymal transition via AMPK/mTOR signalling pathway in ovarian cancer SKOV-3 and A2780 cells
| JOURNAL OF CELLULAR AND MOLECULAR MEDICINE |
| 2012 | Nanog signaling in cancer promotes stem-like phenotype and immune evasion
| JOURNAL OF CLINICAL INVESTIGATION |
| 2023 | Nectin-4 as a Predictive Marker for Poor Prognosis of Endometrial Cancer with Mismatch Repair Impairment
| CANCERS |
| 2003 | New approaches to functional process discovery in HPV 16-associated cervical cancer cells by gene ontology
| CANCER RESEARCH AND TREATMENT |
| 2021 | Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial | LANCET ONCOLOGY |
| 2002 | Osteopontin as apotential diagnostic biomarker for ovarian cancer | JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION |
| 2003 | Osteopontin is down-regulated in hydatidiform mole | GYNECOLOGIC ONCOLOGY |
| 2016 | Over-expression of BMI1 is associated with favorable prognosis in cervical cancer
| INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY |
| 2022 | Overexpression of glucocorticoid receptor promotes the poor progression and induces cisplatin resistance through p38 MAP kinase in cervical cancer patients
| AMERICAN JOURNAL OF CANCER RESEARCH |
